PCMA pointed to a blog post written by CEO JC Scott, which said PBMs are “voluntarily paying dispensing fees for these drugs, which are not technically covered by Medicare and other insurance,” and “most PBMs are paying standard or Medicaid-level” fees.
The Pharmaceutical Care Management Association, which represents the pharmacy middlemen that help decide how a drug will be covered by insurance, said in an email that its members are “stepping up to support the government’s efforts” to provide effective Covid-19 treatments and that they are “making voluntary payments to pharmacies in order to maintain appropriate access to the medications for patients.”
The new Biden administration has started off strong, taking a thoughtful approach to any number of critical health care issues and pulling back a number of new regulations to take a fresh look at these public policy issues. To avoid
©2024 PCMA. All Rights Reserved.
